Q4 2024 Earnings Conference Call January 31, 2025 9:00 AM ETCompany ParticipantsKate Winslow - IRChad Abraham - ...
He noted that advisory services accounted for over half of firmwide net revenues for the fourth consecutive year. Abraham stated that the company completed the acquisition of Aviditi Advisors, ...
Piper Sandler analyst Nathan Race reiterated a Buy rating on First Merchants (FRME – Research Report) today and set a price target of $55.00.
Piper Sandler made a slight adjustment to the price target of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), bringing it down to $533 from the previous target of $535, while maintaining an ...
Piper Sandler adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN) shares, reducing it from the previous $1,195.00 to $1,013.00. Despite this change, the firm maintained its ...